Overview

Comparison Between Rifampicin and Gemifloxacin and Ciprofloxacin in Treatment of Rhinoscleroma

Status:
Unknown status

Trial end date:
2018-10-01

Target enrollment:
0

Participant gender:
All

Summary

gemifloxacin versus ciprofloxacin and rifampicin in treatment of rhinoscleroma

Phase:

Early Phase 1

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Assiut University

Treatments:

Ciprofloxacin
Fluoroquinolones
Gemifloxacin
Rifampin

Criteria

Inclusion Criteria:

1. Age above 18 years

2. Active rhinoscleroma proved both clinically and histopathologically

Exclusion Criteria:

1. Patients younger than 18 years old.

2. inactive Rhinoscleroma

3. Contraindication to treatment severe renal or hepatic impairment

4. Refusal of enrollment in the research by the patient